Global Oncology Market Strategic Research Report 2026-2031

The global oncology market continues to expand rapidly as immunotherapy, antibody-drug conjugates (ADCs), and cell and gene therapy platforms mature into commercial-scale treatment options. As per this report, the global oncology market which was worth USD 278.6 billion in 2025 is expected to grow at a CAGR of 11.0% between 2026 and 2031, reaching approximately USD 521.0 billion by 2031.

This report's bottom-up company-level revenue reconciliation, cross-validated against ten major oncology companies' own disclosed figures, confirms the headline market sizing independently -- including real, disclosed variance at the company level (Pfizer +USD 4.8 billion above initial assumption, AbbVie -USD 1.3 billion below initial assumption), with overall reconciliation accuracy within 0.2% of the companion Pharmaceuticals Industry report's oncology segment figure.

Three structural supercycles are reshaping the competitive landscape simultaneously: the maturation of antibody-drug conjugates as a distinct therapeutic modality beyond traditional chemotherapy, continued expansion of checkpoint inhibitor immunotherapy into earlier treatment lines and additional tumor types, and the accelerating commercial scale-up of CAR-T and other cell-based therapies, particularly in hematological malignancies.

This report profiles ten key companies including Pfizer, AbbVie, and other major oncology franchise holders, with detailed segment-level revenue reconciliation, competitive landscape analysis, and SWOT assessment through 2031.

Scope of Global Oncology Market Strategic Research Report 2026-2031

• This report provides forecast data by value (USD Billion) for the global oncology market, with 2025 as the base year and forecasting to 2031.
• This report provides segmentation by treatment modality (immunotherapy, ADCs, cell and gene therapy, traditional chemotherapy) and by tumor type.
• This report provides region-wise forecast data by value.
• This report identifies key growth drivers and inhibitors affecting the global oncology market.
• This report provides company profiles including Company Overview, Key Products, Financial Performance, Business Strategy, and SWOT Analysis for ten key companies.
• This report provides Porter's Five Forces, PESTLE, and SWOT analysis for the global oncology market.
• This report identifies key future trends in the global oncology market through 2031.

Who can use the Global Oncology Market Research Report?

This research report is ideal for people who wish to gain a thorough understanding of the oncology market. Some of the intended users for this report are:

• C-level executives and Company Directors in pharmaceutical and biotechnology companies
• Commercial strategy and market access professionals
• Industry consultants and Management consultants
• Investment managers, Financial professionals, and Venture Capitalists
• Bank Managers, M&A Managers, and Auditors
• Anyone operating in the oncology drug value chain.